FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre

Název česky	FEIBA(R) v léčbě akutního krvácení u pacientů s hemofilií A a inhibitorem faktoru VIII: retrospektivní studie regionálního centra
Autoři	SMEJKAL Petr BRABEC Petr MATÝŠKOVÁ Miloslava BULIKOVÁ Alena ŠLECHTOVÁ Marie KISSOVÁ Jarmila CHLUPOVÁ Gabriela MUŽÍK Jan PENKA Miroslav
Rok publikování	2009
Druh	Článek v odborném periodiku
Časopis / Zdroj	Haemophilia
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Obor	Onkologie a hematologie
Klíčová slova	haemophilia; bleeding; FEIBA
Popis	FEIBA(R) is used to achieve haemostasis in haemophiliacs with inhibitor. The aim of this study was to evaluate efficacy and consumption of the product in treatment of haemorrhages in haemophiliacs with factor VIII inhibitor, and determine factors that can influence the results of treatment. We used data from our haemophilia centre from years 2000-2008. Six haemophiliacs with factor VIII inhibitor were treated on demand with FEIBA(R) for 61 bleeding episodes (45 haemarthroses, six muscle bleeds, six other sites bleeds and four multiple sites bleeds).